Company Announcements:
(reported by the Company)
No items found
Elevator Pitch:

Nucleotrace has developed the first product-integrated supply chain monitoring and anti-counterfeiting technology for consumable products. Information such as the batch number, expiry date and manufacturing facility are encoded into fragments of DNA which are incorporated into the product as a non-toxic molecular fingerprint. Nucleotrace technology has the capacity to significantly reduce drug counterfeiting which is responsible for one million deaths and costs the pharmaceuticals industry $100 billion each year.

Category: Defence, Health & biotech
Operational Status: Active
ASX Listing Code (if applicable):
Year of Commencement:

Inspire9, 41 Stewart St.
​Richmond, Melbourne, 3121

State: Victoria
Overseas Operations: No
Key Personnel:
Awards won:
Current Period Rank:


    Won Tech23's Innovation Excellence Award and Addisons Award


    October, 2017

    Accepted into Startmate accelerator (includes $75k funding)

Company News:

NOTE: Company News, Milestones and Funding are as collected by Techboard as part of our Monthly Startup Ranking

Amount Seeking:
Type of capital raise:
Pre-money valuation:
ESIC Status:
ESIC Upload:
Future Intentions:
Investment Video:
Investment Pitchdeck:
Investment URL:
Investment Phone:
Investment Email: